Influenza News and Research

Latest Influenza News and Research

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Researchers developed a novel computational model to predict the binding affinity between the hACE2 receptor and the RBD of S protein of SARS-CoV-2.

17 Feb 2022

Smartphone-based COVID-19 detection system

In this interview, we speak to Professor Michael Mahan about his latest research which aimed to bring low-cost, state-of-the-art diagnostics to resource-limited settings.

17 Feb 2022

The emergence of infectious diseases from the "germ’s eye view”

The study highlighted that the disruption caused by the COVID-19 pandemic has shown that human societies remain ill-prepared and susceptible to novel infectious diseases.

16 Feb 2022

Government asks experts to inform the refresh of UK's Biological Security Strategy

The Government is today (Wednesday 16 February) asking for health and security experts to inform the refresh of the UK's Biological Security Strategy, which aims to protect the country from a range of biological threats, including emerging infectious diseases and potential misuse by hostile actors.

15 Feb 2022

UK's fight against zoonotic diseases receives a £200 million boost

The UK's fight against zoonotic diseases, including avian flu and bovine tuberculosis received a major boost today (16 February) with the allocation of £200 million for a programme of investment into world leading research facilities.

15 Feb 2022

South African population reveal durable protection by prior infection against pre-Omicron variants

A recent study explored the buildup of immunity developed post-SARS-CoV-2 infection in African people and the impact of SARS-CoV-2 Omicron VOC on the COVID-19 pandemic.

15 Feb 2022

Estimates of COVID-19 hospitalization and ICU burden from existing severe acute respiratory infections surveillance

Researchers estimated SARS-CoV-2 hospitalization and ICU treatment during the first three waves of the COVID-19 pandemic.

15 Feb 2022

Study suggests that epigenetic memory in innate immune cells could be the key to explaining long COVID

A new study may provide a partial explanation for the long-term immunologic phenomena associated with COVID-19.

15 Feb 2022

SARS-CoV-2 transmission in transmission pairs of school-aged children during the COVID-19 pandemic in the Netherlands

Researchers evaluated whether SARS-CoV-2 transmission among school-aged children in the Netherlands follows a bipartite school and household network.

15 Feb 2022

OxDX raises £2.6M pre-seed funding to develop AI powered rapid diagnostic technology

OxDX has raised £2.6m in pre-seed funding for its AI powered diagnostic technology that can recognise and identify specific species and strains of viruses.

15 Feb 2022

First survey on Omicron BA.2 in France

In a recent study posted to the medRxiv* preprint server, researchers described the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 21L/BA.2 Omicron variant in south-eastern France.

14 Feb 2022

90 minutes of exercise after vaccination may provide an extra immune boost

Researchers at Iowa State University found 90 minutes of mild- to moderate-intensity exercise directly after a flu or COVID-19 vaccine may provide an extra immune boost.

12 Feb 2022

SARS-CoV-2 nucleocapsid G215C variation may explain Delta severity

A new study shows that the SARS-CoV-2 nucleocapsid protein has unique properties that allow the virus to become more infective in the presence of certain mutations.

11 Feb 2022

Spillover of SARS-CoV-2 Omicron variant infection in white-tailed deer in New York

Researchers detected evidence for SARS-CoV-2 Omicron variant exposure in the white-tailed deer population inhabiting Staten Island in New York.

10 Feb 2022

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

In two recent studies, researchers at Washington University School of Medicine in St. Louis found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.

10 Feb 2022

Influenza News and Research

Latest Influenza News and Research

A novel consensus-based computational pipeline that reliably predicts hACE2-RBD binding affinity

Smartphone-based COVID-19 detection system

The emergence of infectious diseases from the "germ’s eye view”

Government asks experts to inform the refresh of UK's Biological Security Strategy

UK's fight against zoonotic diseases receives a £200 million boost

South African population reveal durable protection by prior infection against pre-Omicron variants

Estimates of COVID-19 hospitalization and ICU burden from existing severe acute respiratory infections surveillance

Study suggests that epigenetic memory in innate immune cells could be the key to explaining long COVID

SARS-CoV-2 transmission in transmission pairs of school-aged children during the COVID-19 pandemic in the Netherlands

OxDX raises £2.6M pre-seed funding to develop AI powered rapid diagnostic technology

First survey on Omicron BA.2 in France

90 minutes of exercise after vaccination may provide an extra immune boost

SARS-CoV-2 nucleocapsid G215C variation may explain Delta severity

Spillover of SARS-CoV-2 Omicron variant infection in white-tailed deer in New York

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

Wearable devices can help monitor wellness during recovery from COVID-19

Implications of the SARS-CoV-2 pandemic on influenza epidemics

Exploring the high incidence of croup in children during the SARS-CoV-2 Omicron wave

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

First case of avian influenza A(H5N1) in asymptomatic flock owner in Europe

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Influenza News and Research

Latest Influenza News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in